(53) also predicted that ARMH4 may act as a modulator for QKI, KH domain containing RNA binding, one of the key RNA-binding proteins shown in TCGA-KIRC dataset, and may change its splicing regulation in kidney cancer (53). This evidence concerns the gene ARMH4 and kidney cancer.